SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004898
Filing Date
2022-03-31
Accepted
2022-03-31 16:02:56
Documents
69
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K blph-20211231x10k.htm   iXBRL 10-K 2194656
2 EX-23.1 blph-20211231xex23d1.htm EX-23.1 2922
3 EX-31.1 blph-20211231xex31d1.htm EX-31.1 12118
4 EX-31.2 blph-20211231xex31d2.htm EX-31.2 12116
5 EX-32 blph-20211231xex32.htm EX-32 11603
6 GRAPHIC blph-20211231x10k003.jpg GRAPHIC 20863
  Complete submission text file 0001558370-22-004898.txt   7804688

Data Files

Seq Description Document Type Size
7 EX-101.SCH blph-20211231.xsd EX-101.SCH 46668
8 EX-101.CAL blph-20211231_cal.xml EX-101.CAL 45519
9 EX-101.DEF blph-20211231_def.xml EX-101.DEF 184709
10 EX-101.LAB blph-20211231_lab.xml EX-101.LAB 429663
11 EX-101.PRE blph-20211231_pre.xml EX-101.PRE 334522
63 EXTRACTED XBRL INSTANCE DOCUMENT blph-20211231x10k_htm.xml XML 1365103
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36845 | Film No.: 22792328
SIC: 2834 Pharmaceutical Preparations